New insights into lung health risk for female farmers

Exposure to a mix of common airborne contaminants could lead to lung effects in women who work on farms

Exposure to a mix of common airborne agricultural contaminants could lead to lung effects in females, a new University of Saskatchewan (USask) study has uncovered.

Farmers are exposed daily to a variety of potential contaminants such as endotoxins (substances associated with certain bacteria) in dust, which are well-known to trigger lung inflammation and asthma. However, how endotoxins specifically impact women’s health is not well understood, particularly when there is also exposure to a herbicide called glyphosate, widely used in agricultural work.

Now, USask researchers have detected lung effects in female mice models just five days after a combined exposure, simulating the same quantity of endotoxins and herbicide farmers could breathe over a work week.

The team was able to take detailed images of the affected lungs thanks to the powerful X-rays of the Canadian Light Source (CLS) at USask.

These images showed that fluid had built up in the lungs during this short exposure period. The alveoli – the small air sacks that play a crucial role in breathing – also became thicker, overall showing more impact than that found in mice dosed only with a single contaminant.

These results were recently published in Scientific Reports as one of the first studies focusing on agricultural airborne exposure in female mice.

“Five days is a very short time but still we were able to pick up really fine nuances. The combination of endotoxins and glyphosate was making the lungs as thick, if not more,” said Gurpreet Aulakh, Fedoruk Chair in Imaging Science and associate professor in the Western College of Veterinary Medicine at USask.

Read more on the CLS website

UK and France launch biomedical and AI health alliance to accelerate research into major diseases

A new partnership will unite expertise, infrastructure and data across borders to accelerate diagnosis, treatment and ultimately prevention of major diseases – starting with women’s health, infectious diseases and pandemic preparedness.

Diamond Light Source, the University of Oxford, Université Paris Cité, the Institut Pasteur and Synchrotron SOLEIL have signed a landmark agreement establishing a major new UK-France scientific alliance designed to strengthen how diseases are understood, diagnosed, treated and ultimately prevented.

The partnership comes at a time when advances in science and technology are generating unprecedented amounts of biological and clinical data, as well as transforming our understanding of human health. But turning that information into faster diagnoses, better treatments and improved disease prevention remains a major challenge across disciplines, institutions and national systems.

The UK–France Strategic Biomedical Alliance in Health and AI has been established to address that challenge by connecting world-leading expertise and national infrastructure into a single collaboration. The interdisciplinary model will unite clinical research, molecular biology, engineering, advanced imaging, data science, artificial intelligence and translational medicine across both countries, making it faster and easier for researchers to connect the technologies, expertise and data needed to tackle complex disease.  

Read more on the Diamond website

Image: Dr Jean Susini, Director General, Synchrotron SOLEIL. Sir Thomas Drew KCMG, His Majesty’s Ambassador to France. Professor Richard Cornall, Head of the Nuffield Department of Medicine, University of Oxford. Professor Matthieu Resche-Rigon, Dean of the Health Faculty, Université Paris Cité. Jean-Luc Moullet, Director General for Research and Innovation, French Ministry of Higher Education, Research and Space. Dr Martin Walsh, Interim Director of Life Sciences, Diamond Light Source. Dr Odette Tomescu-Hatto, Director of International Affairs, Institut Pasteur.

Credit: The Department for Science, Innovation and Technology (DSIT)